Integrase inhibitor
This page covers all Integrase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting HIV integrase, Integrase.
Targets
Marketed (1)
- Integrase Inhibitor · McGill University Health Centre/Research Institute of the McGill University Health Centre · Infectious Disease
Integrase inhibitors block HIV integrase, preventing the virus from inserting its genetic material into the host cell's DNA.
Phase 3 pipeline (1)
- RPV LA · ViiV Healthcare · Infectious Disease
RPV LA is a long-acting integrase inhibitor used to treat HIV-1 infection.